GT200000085A - Amidas sustituidas del acido fenilciclohexanocarboxilico (inhibidores de la incorporacion de adenosina) - Google Patents
Amidas sustituidas del acido fenilciclohexanocarboxilico (inhibidores de la incorporacion de adenosina)Info
- Publication number
- GT200000085A GT200000085A GT200000085A GT200000085A GT200000085A GT 200000085 A GT200000085 A GT 200000085A GT 200000085 A GT200000085 A GT 200000085A GT 200000085 A GT200000085 A GT 200000085A GT 200000085 A GT200000085 A GT 200000085A
- Authority
- GT
- Guatemala
- Prior art keywords
- therapy therapy
- refers
- clohexanocarboxilic
- adhesine
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Abstract
LA INVENCION SE REFIERE A COMPUESTOS DE FORMULA I, DONDE "A,D,E Y G" SON IGUALES O DIFERENTES Y CORRESPONDEN A GRUPOS CH O ATOMOS DE NITROGENO. "L" = H, HALOGENOS, HIDROXI, CARBOXILO, CIANO, NITRO, TRIFLUOROMETILO, TRIFLUORMETOXI, ALQUILO, ALCOXI O ALCOXICARBONILO; LA INVENCION TAMBIEN SE REFIERE A LOS PROCEDIMIENTOS PARA SU OBTENCION Y A SU USO EN MEDICAMENTOS. EL COMPUESTO ES UN INHIBIDOR DE ADENOSINA LO CUAL INTENSIFICA EL EFECTO DE LA ADENOSINA LOCAL FORMADA POR LA ISQUEMIA Y DILATA POR TANTO LOS VASOS SANGUINEOS, ASI ENTONCES PUEDEN UTILIZARSE MEDIANTE ADMINISTRACION ORAL O INTRAVENOSA PARA LA PROFILAXIS Y TERAPIA DE ENFERMEDADES ISQUEMICAS, POR EJEMPLO DE ENFERMEDADES CORONARIAS, ANGINAS DE PECHO, ENFERMEDADES OCULARES, INFARTO AL MIOCARDIO, ASI MISMO SON UTILES PARA LA POTENCIACION DEL EFECTO DE ANTIMETABOLITOS NUCLEOBASICOS, NECLEOSIDOS O NUCLEOTIDOS EN EL TRATAMIENTO QUIMIOTERAPEUTICO DEL CANCER Y LA QUIMIOTERAPIA ANTIVIRICA ( POR EJEMPLO VIH). LA INVENCION TAMBIEN SE REFIERE A LOS ENANTIOMEROS Y DIASTEROISOMEROS, LAS SALES, HIDRATOS Y PROMEDICAMENTOS DEL COMPUESTO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19924819A DE19924819A1 (de) | 1999-05-29 | 1999-05-29 | Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren) |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200000085A true GT200000085A (es) | 2001-11-17 |
Family
ID=7909713
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200000085A GT200000085A (es) | 1999-05-29 | 2000-05-26 | Amidas sustituidas del acido fenilciclohexanocarboxilico (inhibidores de la incorporacion de adenosina) |
Country Status (25)
Country | Link |
---|---|
US (1) | US6984642B1 (es) |
EP (1) | EP1187812B1 (es) |
JP (1) | JP2003500474A (es) |
KR (1) | KR20020000814A (es) |
CN (1) | CN1165526C (es) |
AR (1) | AR029639A1 (es) |
AT (1) | ATE303995T1 (es) |
AU (1) | AU766140B2 (es) |
BR (1) | BR0011049A (es) |
CA (1) | CA2375188A1 (es) |
CO (1) | CO5170503A1 (es) |
DE (2) | DE19924819A1 (es) |
DK (1) | DK1187812T3 (es) |
ES (1) | ES2248071T3 (es) |
GT (1) | GT200000085A (es) |
HK (1) | HK1047107B (es) |
HN (1) | HN2000000078A (es) |
IL (1) | IL146231A0 (es) |
MX (1) | MXPA01012240A (es) |
PE (1) | PE20010132A1 (es) |
PL (1) | PL365960A1 (es) |
TR (1) | TR200103398T2 (es) |
UY (1) | UY26179A1 (es) |
WO (1) | WO2000073274A2 (es) |
ZA (1) | ZA200108894B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10150310A1 (de) * | 2001-10-11 | 2003-04-24 | Bayer Ag | Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung |
KR100762858B1 (ko) * | 2005-03-07 | 2007-10-02 | 김기완 | Pe시트를 이용한 저수조의 방수 공법 |
KR100762857B1 (ko) * | 2005-03-07 | 2007-10-02 | 김기완 | Pe시트를 이용한 저수조의 방수 공법 |
KR100745024B1 (ko) * | 2005-05-09 | 2007-08-01 | 김준 | 거푸집 수평조절장치 |
WO2010009068A2 (en) * | 2008-07-16 | 2010-01-21 | Bristol-Myers Squibb Company | Cyclohexenyl modulators of chemokine receptor activity |
EP2380595A1 (en) | 2010-04-19 | 2011-10-26 | Nlife Therapeutics S.L. | Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69322707T2 (de) * | 1992-07-31 | 1999-08-19 | Bristol Myers Squibb Co | Diphenyl Oxazole-, Thiazole- und Imidazole-Derivate als Inhibitoren der Wiederaufnahme des Adenosins |
DE4304455A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate |
DE19503160A1 (de) * | 1995-02-01 | 1996-08-08 | Bayer Ag | Verwendung von Phenylcyclohexylcarbonsäureamiden |
CZ65398A3 (cs) * | 1995-09-22 | 1998-07-15 | Sumitomo Chemical Company, Limited | Derivát pyrazinu-2-on, způsob kontroly nechtěných plevelů a použití derivátu |
US5723313A (en) * | 1995-09-27 | 1998-03-03 | St. Jude Children's Research Hospital | ARF-p19, a novel regulator of the mammalian cell cycle |
-
1999
- 1999-05-29 DE DE19924819A patent/DE19924819A1/de not_active Withdrawn
-
2000
- 2000-05-16 KR KR1020017015253A patent/KR20020000814A/ko not_active Application Discontinuation
- 2000-05-16 MX MXPA01012240A patent/MXPA01012240A/es active IP Right Grant
- 2000-05-16 AT AT00925290T patent/ATE303995T1/de not_active IP Right Cessation
- 2000-05-16 CA CA002375188A patent/CA2375188A1/en not_active Abandoned
- 2000-05-16 AU AU44057/00A patent/AU766140B2/en not_active Ceased
- 2000-05-16 EP EP00925290A patent/EP1187812B1/de not_active Expired - Lifetime
- 2000-05-16 PL PL00365960A patent/PL365960A1/xx not_active Application Discontinuation
- 2000-05-16 DE DE50011122T patent/DE50011122D1/de not_active Expired - Fee Related
- 2000-05-16 ES ES00925290T patent/ES2248071T3/es not_active Expired - Lifetime
- 2000-05-16 JP JP2000621340A patent/JP2003500474A/ja active Pending
- 2000-05-16 IL IL14623100A patent/IL146231A0/xx unknown
- 2000-05-16 TR TR2001/03398T patent/TR200103398T2/xx unknown
- 2000-05-16 US US09/980,242 patent/US6984642B1/en not_active Expired - Fee Related
- 2000-05-16 CN CNB008082170A patent/CN1165526C/zh not_active Expired - Fee Related
- 2000-05-16 DK DK00925290T patent/DK1187812T3/da active
- 2000-05-16 WO PCT/EP2000/004431 patent/WO2000073274A2/de not_active Application Discontinuation
- 2000-05-16 BR BR0011049-3A patent/BR0011049A/pt not_active IP Right Cessation
- 2000-05-17 HN HN2000000078A patent/HN2000000078A/es unknown
- 2000-05-24 CO CO00038312A patent/CO5170503A1/es not_active Application Discontinuation
- 2000-05-26 PE PE2000000505A patent/PE20010132A1/es not_active Application Discontinuation
- 2000-05-26 GT GT200000085A patent/GT200000085A/es unknown
- 2000-05-29 AR ARP000102649A patent/AR029639A1/es not_active Application Discontinuation
- 2000-05-29 UY UY26179A patent/UY26179A1/es not_active Application Discontinuation
-
2001
- 2001-10-29 ZA ZA200108894A patent/ZA200108894B/xx unknown
-
2002
- 2002-12-04 HK HK02108818.1A patent/HK1047107B/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AR029639A1 (es) | 2003-07-10 |
CA2375188A1 (en) | 2000-12-07 |
KR20020000814A (ko) | 2002-01-05 |
HK1047107A1 (en) | 2003-02-07 |
CN1353693A (zh) | 2002-06-12 |
JP2003500474A (ja) | 2003-01-07 |
EP1187812A2 (de) | 2002-03-20 |
IL146231A0 (en) | 2002-07-25 |
ES2248071T3 (es) | 2006-03-16 |
US6984642B1 (en) | 2006-01-10 |
TR200103398T2 (tr) | 2002-03-21 |
BR0011049A (pt) | 2002-03-19 |
ATE303995T1 (de) | 2005-09-15 |
AU766140B2 (en) | 2003-10-09 |
DK1187812T3 (da) | 2005-12-12 |
PE20010132A1 (es) | 2001-04-12 |
WO2000073274A3 (de) | 2001-04-19 |
MXPA01012240A (es) | 2002-08-12 |
WO2000073274A2 (de) | 2000-12-07 |
AU4405700A (en) | 2000-12-18 |
EP1187812B1 (de) | 2005-09-07 |
HK1047107B (zh) | 2005-05-20 |
DE50011122D1 (de) | 2005-10-13 |
HN2000000078A (es) | 2001-02-02 |
ZA200108894B (en) | 2003-01-29 |
DE19924819A1 (de) | 2000-11-30 |
CO5170503A1 (es) | 2002-06-27 |
PL365960A1 (en) | 2005-01-24 |
UY26179A1 (es) | 2000-12-29 |
CN1165526C (zh) | 2004-09-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR008377A1 (es) | Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto | |
ES2039278T3 (es) | Procedimiento para preparar inhibidores de 5-alfa-reductasa de esteroides. | |
RU95108387A (ru) | Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина | |
AR007456A1 (es) | Compuestos derivados de indazol sustituido y composiciones farmaceuticas que lo contienen | |
PE20040937A1 (es) | Derivados de piridazin-3(2h)-ona como inhibidores de fosfodiesterasa-4 (pde 4) | |
AR047531A1 (es) | Derivados 1h-tieno(2,3-c)pirazol utiles como inhibidores de quinasa | |
ZA200406709B (en) | Pyrimidine derivatives | |
ES2188005T3 (es) | Derivados de amidas para el tratamiento de enfermedades mediadas por citoquinas. | |
MA27654A1 (fr) | DERIVES HEXAHYDROPYRAZINO [1,2-a]-4,7-DIONE SUBSTITUES, METHODE POUR LEUR PRODUCTION ET LEUR UTILISATION EN TANT QUE MEDICAMENTS | |
HN1997000046A (es) | Derivados de indazol sustituidos y compuestos relacionados | |
BRPI0413452A (pt) | composto, composição farmacêutica, kit, artigo de fabricação, e, métodos de inibir dpp-iv, terapêutico e de tratar um estado de doença, cáncer, distúrbios autoimunes, uma condição einfecção por hiv | |
CL2021001396A1 (es) | Derivados de panteteína y usos de los mismos | |
AR027464A1 (es) | Oxamidas que son inhibidores de la inosina monofosfato deshidrogenasa (impdh) | |
HUP0105414A2 (hu) | Pirrolo-izokinolin-, azepino- és diazepino-indol-származékok, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények | |
KR960705810A (ko) | 퀴나졸린 유도체(quinazoline derivatives) | |
PA8432901A1 (es) | Compuestos de piridilpirrol | |
ECSP066349A (es) | Inhibidores de transferasa de proteína de farnesilo novedosos como agentes antitumorales | |
MA28742B1 (fr) | Derives de pyrido-pyrimidine, leur preparation, leur application en therapeutique | |
DK1056704T3 (da) | Antitumormidler | |
UY27786A1 (es) | Derivados de isoquinolina. | |
HUP0203422A2 (hu) | Foszfodiészteráz VII inhibitor hatású imidazolszármazékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
GT200000085A (es) | Amidas sustituidas del acido fenilciclohexanocarboxilico (inhibidores de la incorporacion de adenosina) | |
KR940009184A (ko) | 피라졸 축합환 유도체, 이의 제조방법 및 안드로겐 억제제 | |
ES2062094T3 (es) | Derivados del acido parabanico y composiciones farmaceuticas que los contienen. | |
ES2036137B1 (es) | Procedimiento para la preparacion de la nueva 1-(3-clorofenil)-4-hidroximetil-7,8-dimetoxi-5h-2,3-benzodiacepina y de sus sales de adicion acida. |